D3 Bio

Fore Bio

This biotechnology company develops precision oncology therapies and small-molecule inhibitors for patients with unaddressed tumour mutations and hard-to-treat cancers.

Frontier Medicines

This biopharmaceutical company develops small-molecule precision medicines targeting undruggable proteins for patients with cancer and immunological diseases.

Acrivon Therapeutics

This biopharmaceutical company develops precision oncology medicines and proteomics-based companion diagnostics for cancer patients.

Hummingbird Bioscience

This company develops antibody-based therapeutics and drug conjugates for patients with hard-to-treat cancers and autoimmune diseases.

Beeline Medicines

This clinical-stage biotechnology company develops precision therapies for patients living with autoimmune and inflammatory diseases.

HI-Bio

This biotechnology company develops targeted therapies for patients suffering from severe immune-mediated diseases.

Profound Bio

This clinical-stage biotechnology company develops antibody-drug conjugates and targeted therapies for patients with solid tumors and hematological malignancies.

DEKA Biosciences

This biotechnology firm develops cytokine therapies to treat cancer and inflammatory diseases for patients requiring personalised precision medicine.